While CR3 and CR4 are reported to appear also on B cells of patients suffering from Hodgkin’s lymphoma [12], hairy cell leukaemia [13] or CLL [4, 13–19], the role of these complement receptors on malignant B cells is still in question. This evidence concerns the gene CRIPTOP4 and Hodgkins lymphoma.